Trial intelligence / Profile preview

Cefixime PO vs Ceftriaxone IV/PO for Acute Pyelonephritis in Children

NCT00136656Phase 4Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jul 2005
Primary completion
Jun 2008
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of cefixime in acute pyelonephritis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Renal scars on dimercaptosuccinic acid (DMSA) renal scan at 6 months. Started Jul 2005; status: completed.

02

Drugs

cefixime
03

Conditions

acute pyelonephritis

Beyond the preview

Go deeper on NCT00136656.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00136656.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call